Brinker Capital Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.05M Buy
11,341
+1,768
+18% +$787K 0.04% 387
2025
Q1
$4.64M Buy
9,573
+610
+7% +$296K 0.05% 367
2024
Q4
$3.61M Buy
8,963
+154
+2% +$62K 0.04% 428
2024
Q3
$4.1M Sell
8,809
-710
-7% -$330K 0.04% 399
2024
Q2
$4.46M Buy
9,519
+1,133
+14% +$531K 0.05% 343
2024
Q1
$3.51M Sell
8,386
-1,623
-16% -$678K 0.04% 425
2023
Q4
$4.19M Sell
10,009
-485
-5% -$203K 0.05% 344
2023
Q3
$3.65M Sell
10,494
-1,048
-9% -$364K 0.04% 379
2023
Q2
$4.06M Buy
11,542
+662
+6% +$233K 0.04% 374
2023
Q1
$3.43M Buy
10,880
+2,955
+37% +$931K 0.04% 373
2022
Q4
$2.29M Sell
7,925
-1,258
-14% -$363K 0.05% 420
2022
Q3
$2.66M Sell
9,183
-480
-5% -$139K 0.06% 350
2022
Q2
$2.72M Sell
9,663
-3,718
-28% -$1.05M 0.05% 356
2022
Q1
$3.49M Sell
13,381
-43
-0.3% -$11.2K 0.05% 336
2021
Q4
$2.95M Buy
13,424
+2,301
+21% +$505K 0.04% 426
2021
Q3
$2.24M Hold
11,123
0.04% 521
2021
Q2
$2.24M Buy
11,123
+36
+0.3% +$7.26K 0.03% 574
2021
Q1
$2.38M Sell
11,087
-11,596
-51% -$2.49M 0.04% 458
2020
Q4
$5.36M Buy
22,683
+12,838
+130% +$3.03M 0.08% 285
2020
Q3
$2.68M Buy
+9,845
New +$2.68M 0.05% 382
2020
Q1
Sell
-72
Closed -$16K 756
2019
Q4
$16K Buy
72
+5
+7% +$1.11K ﹤0.01% 528
2019
Q3
$11K Sell
67
-436
-87% -$71.6K ﹤0.01% 569
2019
Q2
$92K Buy
503
+229
+84% +$41.9K ﹤0.01% 498
2019
Q1
$50K Buy
+274
New +$50K ﹤0.01% 475
2016
Q4
Sell
-3
Closed 652
2016
Q3
$0 Buy
+3
New ﹤0.01% 630
2016
Q1
Sell
-12
Closed -$2K 690
2015
Q4
$2K Buy
12
+3
+33% +$500 ﹤0.01% 475
2015
Q3
$1K Buy
+9
New +$1K ﹤0.01% 442